 |
diaDexus, Inc. Reports First Quarter 2013 Financial Results
May 6, 2013
|
23.5 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., May 6, 2013 (GLOBE NEWSWIRE) -- diaDexus, Inc. (OTCQB:DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced financial results for the first quarter ended March 31, 2013.
Brian Ward, Ph.D., diaDexus' President and Chief Executive Officer, said, "diaDexus h...
|
|
diaDexus Inc. to Present at the Taglich Brothers 10th Annual Small Cap Equity Conference
Apr 18, 2013
|
13.2 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., April 18, 2013 (GLOBE NEWSWIRE) -- diaDexus, Inc. (OTCQB:DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced that Brian E. Ward, Ph.D., Chief Executive Officer, is scheduled to present at the Taglich Brothers 10th Annual Small Cap Equity Conference in New York....
|
|
diaDexus, Inc. to Host Conference Call and Webcast May 6, 2013 to Discuss First Quarter 2013 Financial Results
Apr 17, 2013
|
12.9 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., April 17, 2013 (GLOBE NEWSWIRE) -- diaDexus, Inc. (OTCQB:DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced that it will host a conference call and webcast on Monday, May 6, 2013 at 4:30 PM ET (1:30 PM PT) to discuss its 2013 first quarter results.
The...
|
|
diaDexus, Inc. Reports Fourth Quarter and Full Year 2012 Financial Results
Mar 7, 2013
|
25.2 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., March 7, 2013 (GLOBE NEWSWIRE) -- diaDexus, Inc. (OTCQB:DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced financial results for the fourth quarter and full year ended December 31, 2012.
Brian Ward, Ph.D., diaDexus' President and Chief Executive Office...
|
|
diaDexus, Inc. to Host Conference Call and Webcast March 7, 2013 to Discuss Fourth Quarter and Full Year 2012 Financial Results
Feb 12, 2013
|
13.0 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., Feb. 12, 2013 (GLOBE NEWSWIRE) -- diaDexus, Inc. (OTCQB:DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced that it will host a conference call and webcast on Thursday, March 7, 2013 at 4:30 PM ET (1:30 PM PT) to discuss its 2012 fourth quarter and full year re...
|
|
diaDexus, Inc. to Present at the Leerink Swann Global Healthcare Conference
Feb 7, 2013
|
13.2 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., Feb. 7, 2013 (GLOBE NEWSWIRE) -- diaDexus, Inc. (OTCQB:DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced that Brian E. Ward, Ph.D., Chief Executive Officer, is scheduled to present at the Leerink Swann Global Healthcare Conference in New York. Dr. Ward will p...
|
|
diaDexus, Inc. Reports Third Quarter 2012 Financial Results
Nov 7, 2012
|
24.6 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., Nov. 7, 2012 (GLOBE NEWSWIRE) -- diaDexus, Inc. (OTCQB:DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced financial results for the third quarter of 2012.
Brian Ward, Ph.D., diaDexus' President and Chief Executive Officer, said, "We are very pleased to...
|
|
diaDexus Inc. to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
Nov 5, 2012
|
13.3 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., Nov. 5, 2012 (GLOBE NEWSWIRE) -- diaDexus, Inc. (OTCQB:DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced that Brian E. Ward, Ph.D., Chief Executive Officer, is scheduled to present at the Lazard Capital Markets 9th Annual Healthcare Conference in New York. Dr...
|
|
diaDexus, Inc. to Host Conference Call and Webcast November 7, 2012 to Discuss Third Quarter 2012 Financial Results
Oct 31, 2012
|
13.0 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., Oct. 31, 2012 (GLOBE NEWSWIRE) -- diaDexus, Inc. (OTCQB:DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced that it will host a conference call and webcast on Wednesday, November 7, 2012 at 4:30 PM ET (1:30 PM PT) to discuss its 2012 third quarter results.
...
|
|
diaDexus, Inc. to Present at the SeeThruEquity Fall 2012 Smallcap and Microcap Investor Conference
Oct 1, 2012
|
14.0 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., Oct. 1, 2012 (GLOBE NEWSWIRE) -- diaDexus, Inc. (OTCQB:DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced that Brian E. Ward, Ph.D., Chief Executive Officer, is scheduled to present at the SeeThruEquity Fall 2012 Smallcap and Microcap Investor Conference at th...
|
|
diaDexus, Inc. Extends Loan Facility With Comerica Bank
Sep 13, 2012
|
15.1 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., Sept. 13, 2012 (GLOBE NEWSWIRE) -- diaDexus, Inc. (OTCQB:DDXS), a company focused on the development and commercialization of proprietary cardiovascular diagnostic products, today announced that it has entered into an agreement to modify the terms of its existing $5 million loan facility with Comerica Bank. The modified...
|
|
diaDexus, Inc. Reports Second Quarter 2012 Financial Results
Aug 7, 2012
|
23.7 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., Aug. 7, 2012 /PRNewswire/ -- diaDexus, Inc. (OTCQB: DDXS), a company focused on the development and commercialization of proprietary cardiovascular diagnostic products, today announced financial results for the second quarter of 2012.
Total revenues for the second quarter ended June 30, 2012 were $5.1 million, a...
|
|
diaDexus, Inc. to Host Webcast August 7, 2012 on Second Quarter 2012 Financial Results
Jul 30, 2012
|
11.4 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., July 30, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a diagnostics company focused on the development and commercialization of proprietary diagnostic products, today announced that it will host a webcast on Tuesday, August 7 at 4:15 PM ET (1:15 PM PT) to discuss its 2012 second quarter results. The w...
|
|
diaDexus Appoints Dr. Robert Schott as Vice President of Medical Affairs
Jun 13, 2012
|
15.8 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., June 13, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC QB: DDXS), a company focused on the development and commercialization of proprietary cardiovascular diagnostic products, today announced that Robert J. Schott, M.D., M.P.H., F.A.C.C., has been appointed to the position of vice president of medical affairs. Dr. Schott br...
|
|
diaDexus, Inc. Reports 2012 First Quarter Financial Results
May 8, 2012
|
22.2 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., May 8, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a company focused on the development and commercialization of proprietary cardiovascular diagnostic products, today announced financial results for the first quarter of 2012.
Total revenues for the first quarter of 2012 were $4.9 million, a 4...
|
|
diaDexus, Inc. to Host Webcast May 8, 2012 on 2012 First Quarter Financial Results
May 1, 2012
|
11.4 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., May 1, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS.OB), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products, today announced that it will host a webcast on Tuesday, May 8 at 4:15 PM EDT (1:15 PM PDT) to discuss its 2012 first quarter r...
|
|
New Clinical Endocrinology Guidelines Support Lp-PLA2 Measurement For Risk Assessment of Coronary Artery Disease
Apr 26, 2012
|
17.1 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., April 26, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a company focused on the development and commercialization of proprietary cardiovascular diagnostic products, today announced the inclusion of its vascular-specific inflammatory marker Lp-PLA2 in the American Association of Clinical Endocrinologis...
|
|
diaDexus, Inc. Highlights Findings from Two Outcomes Studies for its PLAC Lp-PLA(2) Activity Assay
Mar 19, 2012
|
18.5 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., March 19, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a company focused on proprietary cardiovascular diagnostic products, today highlighted data from two recent studies evaluating the clinical utility of its PLAC® Test for Lp-PLA(2) Activity. The PLAC® Test for Lp-PLA(2) Activity is CE-m...
|
|
diaDexus, Inc. Reports 2011 Fourth Quarter and Year-End Financial Results
Mar 15, 2012
|
24.2 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., March 15, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a company focused on the development and commercialization of proprietary cardiovascular diagnostic products, today announced financial results for the 2011 fourth quarter and year-end.
Fourth quarter 2011
Total revenues for the 2011 fourth...
|
|
diaDexus Launches PLAC® Test for Lp-PLA(2) Activity in Europe
Mar 5, 2012
|
16.5 KB |
|
| |
SOUTH SAN FRANCISCO, March 5, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a company focused on the development and commercialization of proprietary cardiovascular diagnostic products, today announced the commercial launch of its CE-marked PLAC® Test for Lp-PLA(2) Activity in Europe. The PLAC Activity test will be sold in Eu...
|
|
|
Delicious
Digg
Facebook
LinkedIn
Twitter